These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36146553)

  • 1. Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.
    Bellinato F; Fratton Z; Girolomoni G; Gisondi P
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.
    Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A
    Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis.
    Guo Y; Cao XS; Yang HT; Zhou MG; Yu B
    J Glob Health; 2023 Feb; 13():06008. PubMed ID: 36757823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
    Qaderi K; Golezar MH; Mardani A; Mallah MA; Moradi B; Kavoussi H; Shamsabadi A; Golezar S
    Dermatol Ther; 2022 May; 35(5):e15391. PubMed ID: 35194894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines.
    Bellinato F; Maurelli M; Gisondi P; Girolomoni G
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Adverse Events After COVID-19 Vaccination.
    Weschawalit S; Pongcharoen P; Suthiwartnarueput W; Srivilaithon W; Daorattanachai K; Jongrak P; Chakkavittumrong P
    Clin Cosmet Investig Dermatol; 2023; 16():1473-1484. PubMed ID: 37313511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.
    Grieco T; Maddalena P; Sernicola A; Muharremi R; Basili S; Alvaro D; Cangemi R; Rossi A; Pellacani G
    Dermatol Ther; 2021 Nov; 34(6):e15153. PubMed ID: 34622531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.
    Castaldo M; Waliszewska-Prosół M; Koutsokera M; Robotti M; Straburzyński M; Apostolakopoulou L; Capizzi M; Çibuku O; Ambat FDF; Frattale I; Gadzhieva Z; Gallo E; Gryglas-Dworak A; Halili G; Jusupova A; Koperskaya Y; Leheste AR; Manzo ML; Marcinnò A; Marino A; Mikulenka P; Ong BE; Polat B; Popovic Z; Rivera-Mancilla E; Roceanu AM; Rollo E; Romozzi M; Ruscitto C; Scotto di Clemente F; Strauss S; Taranta V; Terhart M; Tychenko I; Vigneri S; Misiak B; Martelletti P; Raggi A;
    J Headache Pain; 2022 Mar; 23(1):41. PubMed ID: 35361131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
    Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
    JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of SARS-CoV-2 Vaccines among Children and Adolescents: A Systematic Review and Meta-Analysis.
    Gao P; Cai S; Liu Q; Du M; Liu J; Liu M
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
    Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
    Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks.
    Esmaeilzadeh A; Maleki AJ; Moradi A; Siahmansouri A; Yavari MJ; Karami P; Elahi R
    Expert Rev Vaccines; 2022 Oct; 21(10):1377-1394. PubMed ID: 35986451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous reactions to COVID-19 vaccine at the dermatology primary care.
    Burlando M; Herzum A; Micalizzi C; Cozzani E; Parodi A
    Immun Inflamm Dis; 2022 Feb; 10(2):265-271. PubMed ID: 34837354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis.
    Mehrabi Nejad MM; Shobeiri P; Dehghanbanadaki H; Tabary M; Aryannejad A; Haji Ghadery A; Shabani M; Moosaie F; SeyedAlinaghi S; Rezaei N
    Virol J; 2022 Aug; 19(1):132. PubMed ID: 35941646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.